These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37806829)

  • 21. Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.
    Keutgen XM; Schadde E; Pommier RF; Halfdanarson TR; Howe JR; Kebebew E
    Semin Oncol; 2018 Aug; 45(4):232-235. PubMed ID: 30318110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases.
    Doah KY; Shin US; Jeon BH; Cho SS; Moon SM
    Ann Coloproctol; 2021 Apr; 37(2):94-100. PubMed ID: 33979907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
    Stiefel R; Lehmann K; Winder T; Siebenhüner AR
    BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors.
    Liu M; Yu H; Chen L; Yang D; Liu H; Ouyang J; Zhang J; Yan X; Luo Y; Lin Y; He Q; Chen M; Zhang N; Wang Y
    Neuroendocrinology; 2024; 114(9):827-839. PubMed ID: 38061350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is metastasectomy a worthy option?-the role of surgery in metastatic colon cancer to liver and lungs.
    Lemini R; Attwood K; Almerey T; Gunn J; Yeager TE; Elias AW; Partain K; Jorgensen MS; Ji W; Gabriel EM; Colibaseanu DT
    J Gastrointest Oncol; 2019 Dec; 10(6):1032-1048. PubMed ID: 31949921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
    Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
    Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors.
    Chawla A; Williams RT; Sich N; Clancy T; Wang J; Ashley S; Pezzi C; Swanson R
    J Surg Oncol; 2018 Nov; 118(6):983-990. PubMed ID: 30212595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases.
    Cloyd JM; Omichi K; Mizuno T; Kawaguchi Y; Tzeng CD; Conrad C; Chun YS; Aloia TA; Katz MHG; Lee JE; Halperin D; Yao J; Vauthey JN; Dasari A
    Ann Surg Oncol; 2018 Jun; 25(6):1709-1715. PubMed ID: 29626307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
    Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
    Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
    Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
    Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors.
    Pandrowala SA; Kapoor D; Kunte A; Chopde A; Puranik A; Dev ID; Parghane R; Basu S; Ramaswamy A; Ostwal V; Chaudhari VA; Bhandare MS; Shrikhande SV
    J Gastrointest Cancer; 2024 Sep; 55(3):1220-1228. PubMed ID: 38874852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis.
    Yao YC; Chen JQ; Yin L; Lin WH; Peng JH; Fan WH
    BMC Gastroenterol; 2022 Mar; 22(1):114. PubMed ID: 35264117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
    Shin Y; Ha SY; Hyeon J; Lee B; Lee J; Jang KT; Kim KM; Park YS; Park CK
    Cancer Res Treat; 2015 Oct; 47(4):738-46. PubMed ID: 25687852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.
    Liu CT; Chen MH; Chen JS; Chen LT; Shan YS; Lu CH; Su YL; Ku FC; Chou WC; Chen YY
    Asia Pac J Clin Oncol; 2016 Dec; 12(4):396-402. PubMed ID: 27357443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery for GEP-NETs.
    Knigge U; Hansen CP
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):819-31. PubMed ID: 23582921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness.
    Barrea L; Altieri B; Muscogiuri G; Laudisio D; Annunziata G; Colao A; Faggiano A; Savastano S
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.
    Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Topp SA; Cupisti K; Knoefel WT
    World J Surg; 2014 Feb; 38(2):392-401. PubMed ID: 24101025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Liver Metastases from Midgut Neuroendocrine Tumours: A Systematic Review and Meta-Analysis.
    Kaçmaz E; Heidsma CM; Besselink MGH; Dreijerink KMA; Klümpen HJ; Nieveen van Dijkum EJM; Engelsman AF
    J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30909512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance.
    Daskalakis K; Tsoli M; Srirajaskanthan R; Chatzellis E; Alexandraki K; Angelousi A; Pizanias M; Randeva H; Kaltsas G; Weickert MO
    Neuroendocrinology; 2019; 108(4):308-316. PubMed ID: 30673674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.